Ticker brief

QNTM QUANTUM BIOPHARMA-B SUB VOT

Consumer, Non-cyclical · Pharmaceuticals

last close
$3.24
1 day
+9.8%
14 days
-5.8%
mkt cap
·
signals 14d
8
authors 14d
6
crowd 14d
-0.0σ
Sentiment — last 14 days
daily mean sentiment, 2026-10-03 → 2026-10-08 · now -0.13 (−1 bearish … +1 bullish)
Who spoke6
authorgradetrader scoresignalsmean sent
@BenzingaC+0.172+0.35
@AGORACOMC+1.742+0.05
@SittingBear0921C-1.311-0.70
@CHItraderB-0.221+0.35
@theflynewsC·1+0.30
@CrweWorldC·1+0.05
Recent signals8of 8 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-10-08@AGORACOM-0.30A law firm was appointed to lead a class action alleging manipulation of QNTM shares.—
2026-10-08@CrweWorld+0.05Reports appointment of lead counsel in a class action alleging manipulation of Quantum BioPharma shares.—
2026-10-06@Benzinga+0.35Thermo Fisher will support Quantum Biopharma's multiple-sclerosis drug trial.—
2026-10-06@AGORACOM+0.40Aggregates five directly affected small-cap company developments involving batteries, trials, drilling and a contract.—
2026-10-06@theflynews+0.30Quantum BioPharma signed a contract with Thermo Fisher for a sclerosis trial.—
2026-10-06@CHItrader+0.35Thermo Fisher's PPD will support QNTM's Phase 2 Lucid-MS trial after FDA clearance.—
2026-10-06@Benzinga+0.35Quantum BioPharma contracted Thermo Fisher's clinical-research business for a Phase 2 trial.—
2026-10-03@SittingBear0921-0.70Accuses associated parties of pump-and-dump conduct and suggests DOJ scrutiny of unreported sales.—

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.